Home › Chronic Kidney Disease › Florida › Lakeland
Chronic Kidney Disease clinical trials in Lakeland, FL
3 studies for Chronic Kidney Disease are looking for participants at sites in and around Lakeland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Lakeland
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
RecruitingPhase 1/2Healthy volunteers welcome
- Clinical Research of Central Florida, Lakeland
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
RecruitingPhase 3
- Research Site, Lakeland
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY16 studies
- Philadelphia, PA15 studies
- Boston, MA15 studies
- Houston, TX14 studies
- Dallas, TX14 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA9 studies
- Kansas City, MO8 studies
- San Antonio, TX8 studies
- Durham, NC8 studies
- Los Angeles, CA7 studies
Other studies in Lakeland
- Breast Cancer7 studies
- Type 2 Diabetes6 studies
- Steatotic Liver Disease5 studies
- Melanoma5 studies
- Colorectal Cancer4 studies
- Lung Cancer4 studies
- Macular Degeneration3 studies
- Heart Failure3 studies
- Crohn's Disease3 studies
- Cardiovascular Disease3 studies
- Peripheral Arterial Disease3 studies
- Non-Small Cell Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.